January 7, 2025 - 16:44

The FDA has released new guidance addressing the use of artificial intelligence (AI) in drug development, emphasizing the potential risks associated with this rapidly evolving technology. The agency warns that improper use of AI could lead to life-threatening consequences, underscoring the critical need for early engagement between sponsors and regulators.
In the guidance, the FDA calls for sponsors to provide comprehensive information about the development and maintenance of AI models. This includes detailed documentation of the algorithms used, data sources, and validation processes. By ensuring transparency and thorough communication, the FDA aims to mitigate risks and enhance the safety and efficacy of AI-driven drug development.
The agency's proactive stance reflects a growing recognition of the complexities and challenges posed by AI technologies in healthcare. As AI continues to play an increasingly prominent role in the pharmaceutical industry, the FDA's guidance serves as a crucial framework for navigating its potential pitfalls while fostering innovation.
June 21, 2026 - 09:03
Micron Technology's Path Over the Next Five YearsA closer look at the memory market`s prospects over the next five years suggests that Micron Technology still has multibagger potential. The company, one of the three dominant players in DRAM and...
June 20, 2026 - 19:51
RLX Technology (RLX) Trading Below Sector Average, Is It The Best Undervalued Stocks Under $5RLX Technology Inc., listed on the NYSE under the ticker RLX, is drawing attention as a potential bargain among stocks priced under five dollars. The company currently trades at a forward...
June 20, 2026 - 01:49
Cherokee Federal named to Washington Technology Top 100 for eighth consecutive yearTULSA - Cherokee Federal, the federal contracting arm of Cherokee Nation Businesses, has secured a place on the Washington Technology Top 100 list for the eighth year in a row. The annual ranking...
June 19, 2026 - 04:27
Technology will continue to drive the ‘roaring 2020s’ to the end of the decade: Ed YardeniEd Yardeni, president of Yardeni Research, argues that the current economic expansion, which he calls the `roaring 2020s,` still has plenty of fuel left thanks to rapid advances in technology....